Provided by Tiger Trade Technology Pte. Ltd.

Rallybio Corp.

16.83
+0.23001.39%
Post-market: 16.830.00000.00%19:30 EDT
Volume:7K
Turnover:115.06K
Market Cap:89.17M
PE:2.11
High:16.95
Open:16.76
Low:16.55
Close:16.60
52wk High:17.57
52wk Low:3.67
Shares:5.30M
Float Shares:2.18M
Volume Ratio:0.47
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.99
EPS(LYR):-1.5948
ROE:64.86%
ROA:-21.32%
PB:0.94
PE(LYR):-10.55

Loading ...

Rallybio CMO Departs Amid Pending Candid Therapeutics Merger

TIPRANKS
·
Apr 01

Rallybio Chief Medical Officer Steven Ryder departs effective immediately

Reuters
·
Apr 01

Rallybio CVRs Carry High Risk of Expiring Worthless Amid Uncertain Asset Monetization

TIPRANKS
·
Mar 18

Rallybio FY2025 net loss narrowed 84.46% to USD 8.98 million

Reuters
·
Mar 17

Rallybio Completes Key FNAIT Risk Study, Laying Groundwork for Future Market Moves

TIPRANKS
·
Mar 07

Rallybio in Reverse Merger With Candid Therapeutics

Dow Jones
·
Mar 02

BRIEF-Rallybio Corporation And Candid Therapeutics Announce Merger Agreement

Reuters
·
Mar 02

Rallybio Corp - Combined Company to Operate as Candid Therapeutics Under Ticker Cdrx

THOMSON REUTERS
·
Mar 02

Rallybio Corp - Candid Secures Oversubscribed and Upsized Private Financing of Over $505 Mln in Gross Proceeds

THOMSON REUTERS
·
Mar 02

Rallybio Corp - Co's Equityholders to Own 3.65% of Combined Company

THOMSON REUTERS
·
Mar 02

Rallybio Corp: Pre-Transaction Rallybio Equityholders Are Expected to Own Approximately 3.65% of Combined Co

THOMSON REUTERS
·
Mar 02

Rallybio Corp - Over $505 Mln Financing Committed by Investors

THOMSON REUTERS
·
Mar 02

Rallybio Corp - Ken Song to Lead Combined Company as CEO

THOMSON REUTERS
·
Mar 02

Rallybio Corp - Pro-Forma Cash of About $700 Mln Expected at Closing

THOMSON REUTERS
·
Mar 02

Rallybio Corp: Combined Company's Cash Balance at Closing Is Expected to Fund Operations Through 2030

THOMSON REUTERS
·
Mar 02

Press Release: Rallybio Corporation and Candid Therapeutics Announce Merger Agreement

Dow Jones
·
Mar 02

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM

Reuters
·
Mar 02

Rallybio’s RLYB116 Clears Phase 1 Milestone, Sharpening Its Autoimmune Pipeline

TIPRANKS
·
Feb 28